U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07733817) titled 'Impact of Probiotic Supplementation on Neuropathy Induced by Adjuvant Chemotherapy in Patients With Colon Cancer: a Phase III Randomized Study' on July 24.
Brief Summary: The pbjective of this study is to assess the impact of a multi-strain bacteria probiotic OXXYSLAB(R) on the reduction of oxaliplatin-induced peripheral neuropathy in patients with stage III colon cancer receiving FOLFOX or XELOX regimen in adjuvant treatment, assessed using the oxaliplatin-specific scale of Levi.
Study Start Date: Oct. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Colon Adenocarcinoma
Neuropathic Pain
Intervention:
DIETARY_SUPPLEMENT: PROBIO...